Inventor · disambiguated record
Haohan Tan
Also filed as: TAN HAOHAN
14 granted patents·5 pending applications·14 citations·filing 2013–2021
85Inventor score
Files withSHANGHAI FOCHON PHARMACEUTICAL CO LTD8FOCHON PHARMACEUTICALS LTD6FOCHON BIOSCIENCES LTD4CHONGQING FOCHON PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
19 records- 0187US11053239B2Compounds as BLC-2-selective apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Jul 6, 2021·6 cites·13 claims
- 0278US11091478B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Aug 17, 2021·2 cites·32 claims
- 0373US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0473US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0571US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 0660US12312349B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2021·Granted May 27, 2025·0 cites·16 claims
- 0751US2023159527A1Compounds as bcl-2 inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0849US2023406856A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 0949US2022354860A1Heterocyclic derivatives and use thereofFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1046US2023145305A1Compounds useful as kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1145US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 1245US2022235049A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1342US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 1439US11168078B2Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenaseSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
- 1537US10800785B2Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·18 claims
- 1636US11555042B2Macrocyclic compounds as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Jan 17, 2023·0 cites·31 claims
- 1736US11459332B2Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Oct 4, 2022·0 cites·22 claims
- 1836US10894038B2Indolizine derivatives, composition and methods of useSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·20 claims
- 1934US10450316B2Certain protein kinase inhibitorCHONGQING FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →